California Pops for $26 Million to Fight Afflictions Ranging from Prostate Cancer to Eye Disease
Former CIRM VP/general counsel on board of directors of $8 million recipient
Directors of the California stem cell and gene therapy program on Tuesday approved $26 million in research awards attacking diseases ranging from eye afflictions to prostate cancer.
The actions came unanimously and marked the addition of the 78th clinical trial to the portfolio of the California Institute for Regenerative Medicine (CIRM)…
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.